OncClub: Join the Chat on Trending Trials in Cancer Complimentary print subscription for home or office delivery In-person and virtual events just for HCPs Lively expert panel discussions featuring peer-to-peer exchanges Subscribe to our eNewsletter for breaking news and curated content

OncClub: Join the Chat on Trending Trials in Cancer Complimentary print subscription for home or office delivery In-person and virtual events just for HCPs Lively expert panel discussions featuring peer-to-peer exchanges Subscribe to our eNewsletter for breaking news and curated content

View More Breast Cancer CAR T-cell Therapy Chronic Lymphocytic Leukemia Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Immuno-Oncology Lung Cancer Melanoma & Skin Cancer Multiple Myeloma Urothelial Cancer

Breast Cancer CAR T-cell Therapy Chronic Lymphocytic Leukemia Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Immuno-Oncology Lung Cancer Melanoma & Skin Cancer Multiple Myeloma Urothelial Cancer

All Oncology News

Pipeline Report

Rare Cancer Series

OncClub All Oncology News Pipeline Report Rare Cancer Series

Medical World News

OncLive News Network®

Thoracic Night Live

Insights Medical World News OncChats OncLive News Network®OncLive TV Peer Exchange Podcasts Rapid Readouts The Talk Thoracic Night Live

Conference Coverage

Conference Listing

Giants of Cancer Care

Scientific Interchanges

State of the Science Summit / IPC

Giants of Cancer Care PER Events Scientific Interchanges State of the Science Summit / IPC Webinars

Oncology Fellows

Supplements And Featured Publications

All Publications

Oncology Live Oncology Fellows Supplements And Featured Publications All Publications

Interactive Tools

Learning Modules

Interactive Tools Learning Modules Presentations Sponsored

Print Subscription

eNewsletter Print Subscription

Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Complimentary print subscription for home or office delivery
In-person and virtual events just for HCPs
Lively expert panel discussions featuring peer-to-peer exchanges
Subscribe to our eNewsletter for breaking news and curated content

SpecialtySee All >

Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer

OncLive SOSS

Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences^™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Inside the Clinic: Global Insights: Multidisciplinary Care of Stage III NSCLC

EP. 1: The Multidisciplinary Care of Stage III NSCLC

May 2nd 2019

EP. 2: Overview of Molecular Testing in Stage III NSCLC

May 2nd 2019

EP. 3: Tissue Collection: In-House Sampling and Reflex Testing

May 2nd 2019

EP. 4: Ensuring Reliable Results From Molecular Testing

May 2nd 2019

EP. 5: Assay Validation and Interdisciplinary Communication

May 2nd 2019

EP. 6: Immunotherapy in Stage III NSCLC

May 2nd 2019

EP. 7: How Durvalumab Has Changed the Standard of Care

May 2nd 2019

EP. 8: Impact of the PACIFIC Study Updated Analysis

May 2nd 2019

EP. 9: Importance of PD-L1 Status in Treating Stage III NSCLC

May 2nd 2019

EP. 10: Recommended Settings for Durvalumab Treatment

May 2nd 2019

<
1
2
>